Published Date: 16 Feb 2023
How is the SARS-CoV-2 mRNA antibody similar to the P.1 gamma strain and other strains?
Read Full NewsA novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.
Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.
Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.
Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.
A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.
People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.
Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.
1.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
2.
Breast cancer prevention: How nurse practitioners and physician assistants can help
3.
Clinical trial sees dramatic results using radiation to treat breast cancer
4.
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer
5.
Lung nodules seen in a high percentage of non-smokers
1.
Best Clinical Practices in Hematology
2.
Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology
3.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
4.
Erythrocyte Functional Impairment During Critical Illness: Mechanisms, Clinical Implications, and Management
5.
Adaptive Rehabilitation Strategies for Advanced Cancer Survivorship
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation